華特達因 (000915.SZ)

35.70 -0.21 (-0.58%) 市場開市。 截至 02:34PM CST。

華特達因

Huate Plaza, No. 17703
Jingshi Road
Jinan 250061
China
86 53 1851 98090
https://www.sd-wit.com

版塊: Healthcare
行業: Drug Manufacturers - Specialty & Generic
全職員工: 1,763

高階主管

名稱	頭銜	支付	行使價	出生年份
Ms. Jie Yang	MD & Director	無	無	1962
Ms. Wei Wang	Financial Director	無	無	1969
Mr. Da Yu Zhang	Deputy GM & Director	無	無	1971
Mr. Zhisheng Fan	Secretary of the Board	無	無	1970
Mr. Ning Fang	Deputy General Manager	無	無	1973

截止 為止計算的金額，現金賠償則計算至上一個財政年度末止。薪資是指薪俸、獎金等。已行使價是指財政年度期間已行使的期權價值。貨幣為 CNY。

描述

Shandong Wit Dyne Health Co.,Ltd. engages in the pharmaceutical business in China. Its medical products include azithromycin granules, licorice zinc granules, compound calcium carbonate, vitamin AD drops, epalrestat tablets, valsartan hydrochlorothiazide gums, roxithromycin, rosiglitazone tartrate tablets, and glimepiride tablets. The company also provides information products, such as DLP splicing display units, LCD splicing display units, image stitching processors, industrial automation control products, and communication products; and crystal products. In addition, it is involved in the provision of education services. The company was founded in 1993 and is based in Jinan, China.

公司管治

截至 無 止，華特達因 的 ISS 管治質素評分為 無。 Pillar 分數正在審核中：無；董事會：無；股東權利：無；現金賠償：無。

企業管治評分的資料提供： Institutional Shareholder Services (ISS). 評分將以 1 至 10 分顯示 (與指數或地區相關)。1 分表示較低的管治風險，而 10 分表示較高的管治風險。